Laboratoires Bailleul
Marco Di Paola is currently working as an Informatore Scientifico specializing in Dermatology and Gynecology at Laboratoires Bailleul. Prior to this, Marco has held various roles in reputable pharmaceutical companies such as DOAFARM Group, PRINCEPS S.R.L, Merqurio, AstraZeneca, AUROBINDO PHARMA LTD, and PromoPharma. With a background in Informazione Scientifica del Farmaco (Farmacia) from Università degli Studi di Palermo, Marco has experience as a Key Account Manager at Medosan / Milafarma and as a Stagista at Fidia Farmaceutici SpA.
This person is not in the org chart
This person is not in any offices
Laboratoires Bailleul
Groupe pharmaceutique français indépendant, les Laboratoires Bailleul proposent médicaments, dermo-cosmétiques et compléments alimentaires assurant une prise en charge globale du patient en dermatologie, santé de la femme et médication familiale. Les Laboratoires Bailleul sont organisés autour de 3 marques: • Bailleul Dermatologie Soins dermo-cosmétiques et compléments alimentaires pour le traitement des cheveux, des ongles et de la peau. • Femilyane Soins dermo-cosmétiques et compléments alimentaires au service de la santé de la femme. • Therica Médication Familiale Dédiée au traitement des pathologies courantes: toux, troubles de la circulation veineuse, verrues, constipation, etc. Le groupe connaît aujourd’hui un développement important à l’international avec 12 filiales et une distribution dans plus de 85 pays dans le monde. *** As an independent French pharmaceutical group, Laboratoires Bailleul offer drugs, dermo-cosmetics and food supplements providing comprehensive patient care in dermatology, women's health and family medication. Laboratoires Bailleul are organized around 3 brands: • Bailleul Dermatologie Dermo-cosmetic care and food supplements for hair, nails and skin treatment. • Femilyane Dermo-cosmetic care and food supplements specially designed for women's health. • Therica Family Medication Dedicated to the treatment of common pathologies: coughs, venous circulation disorders, warts, constipation, etc... The group is growing internationally with currently 12 subsidiaries and a distribution in more than 85 countries around the world.